These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 1521807)
1. Immunohistochemical detection of extravasated fibrinogen (fibrin) in human diabetic retina. Murata T; Ishibashi T; Inomata H Graefes Arch Clin Exp Ophthalmol; 1992; 230(5):428-31. PubMed ID: 1521807 [TBL] [Abstract][Full Text] [Related]
2. Role of VEGF-A in endothelial phenotypic shift in human diabetic retinopathy and VEGF-A-induced retinopathy in monkeys. Hofman P; Blaauwgeers HG; Vrensen GF; Schlingemann RO Ophthalmic Res; 2001; 33(3):156-62. PubMed ID: 11340407 [TBL] [Abstract][Full Text] [Related]
3. Α-Melanocyte-Stimulating Hormone Protects Early Diabetic Retina from Blood-Retinal Barrier Breakdown and Vascular Leakage via MC4R. Cai S; Yang Q; Hou M; Han Q; Zhang H; Wang J; Qi C; Bo Q; Ru Y; Yang W; Gu Z; Wei R; Cao Y; Li X; Zhang Y Cell Physiol Biochem; 2018; 45(2):505-522. PubMed ID: 29402864 [TBL] [Abstract][Full Text] [Related]
5. Three-year follow-up study of blood-retinal barrier and retinal thickness alterations in patients with type 2 diabetes mellitus and mild nonproliferative diabetic retinopathy. Lobo CL; Bernardes RC; Figueira JP; de Abreu JR; Cunha-Vaz JG Arch Ophthalmol; 2004 Feb; 122(2):211-7. PubMed ID: 14769598 [TBL] [Abstract][Full Text] [Related]
6. Histopathology and regression of retinal hard exudates in diabetic retinopathy after reduction of elevated serum lipid levels. Cusick M; Chew EY; Chan CC; Kruth HS; Murphy RP; Ferris FL Ophthalmology; 2003 Nov; 110(11):2126-33. PubMed ID: 14597519 [TBL] [Abstract][Full Text] [Related]
7. Molecular analysis of blood-retinal barrier loss in the Akimba mouse, a model of advanced diabetic retinopathy. Wisniewska-Kruk J; Klaassen I; Vogels IM; Magno AL; Lai CM; Van Noorden CJ; Schlingemann RO; Rakoczy EP Exp Eye Res; 2014 May; 122():123-31. PubMed ID: 24703908 [TBL] [Abstract][Full Text] [Related]
8. Optical coherence tomographic hyperreflective foci: a morphologic sign of lipid extravasation in diabetic macular edema. Bolz M; Schmidt-Erfurth U; Deak G; Mylonas G; Kriechbaum K; Scholda C; Ophthalmology; 2009 May; 116(5):914-20. PubMed ID: 19410950 [TBL] [Abstract][Full Text] [Related]
9. Vascular localization of heparan sulfate proteoglycans in retinas of patients with diabetes mellitus and in VEGF-induced retinopathy using domain-specific antibodies. Witmer AN; van den Born J; Vrensen GF; Schlingemann RO Curr Eye Res; 2001 Mar; 22(3):190-7. PubMed ID: 11462155 [TBL] [Abstract][Full Text] [Related]
10. Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy. Early Treatment Diabetic Retinopathy Study (ETDRS) Report 22. Chew EY; Klein ML; Ferris FL; Remaley NA; Murphy RP; Chantry K; Hoogwerf BJ; Miller D Arch Ophthalmol; 1996 Sep; 114(9):1079-84. PubMed ID: 8790092 [TBL] [Abstract][Full Text] [Related]
11. Two years' fluorescein follow-up of diabetic microaneurysms. Ferrer O Trans Ophthalmol Soc U K (1962); 1966; 86():497-506. PubMed ID: 5226592 [No Abstract] [Full Text] [Related]
12. VEGF-initiated blood-retinal barrier breakdown in early diabetes. Qaum T; Xu Q; Joussen AM; Clemens MW; Qin W; Miyamoto K; Hassessian H; Wiegand SJ; Rudge J; Yancopoulos GD; Adamis AP Invest Ophthalmol Vis Sci; 2001 Sep; 42(10):2408-13. PubMed ID: 11527957 [TBL] [Abstract][Full Text] [Related]
13. Localization of blood-retinal barrier breakdown in human pathologic specimens by immunohistochemical staining for albumin. Vinores SA; Campochiaro PA; Lee A; McGehee R; Gadegbeku C; Green WR Lab Invest; 1990 Jun; 62(6):742-50. PubMed ID: 2193194 [TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical localization of blood-retinal barrier breakdown in human diabetics. Vinores SA; Gadegbeku C; Campochiaro PA; Green WR Am J Pathol; 1989 Feb; 134(2):231-5. PubMed ID: 2916645 [TBL] [Abstract][Full Text] [Related]
15. Alterations of the blood-retinal barrier and retinal thickness in preclinical retinopathy in subjects with type 2 diabetes. Lobo CL; Bernardes RC; Cunha-Vaz JG Arch Ophthalmol; 2000 Oct; 118(10):1364-9. PubMed ID: 11030818 [TBL] [Abstract][Full Text] [Related]
16. The exudative lesions in diabetic retinopathy with special regard to the hard exudate. Yanko L; Ungar H; Michaelson IC Acta Ophthalmol (Copenh); 1974; 52(1):150-60. PubMed ID: 4134583 [No Abstract] [Full Text] [Related]
17. Upregulation of vascular endothelial growth factor in ischemic and non-ischemic human and experimental retinal disease. Vinores SA; Youssri AI; Luna JD; Chen YS; Bhargave S; Vinores MA; Schoenfeld CL; Peng B; Chan CC; LaRochelle W; Green WR; Campochiaro PA Histol Histopathol; 1997 Jan; 12(1):99-109. PubMed ID: 9046048 [TBL] [Abstract][Full Text] [Related]
18. Pathology of diabetic retinopathy. Garner A Br Med Bull; 1970 May; 26(2):137-42. PubMed ID: 4192644 [No Abstract] [Full Text] [Related]
19. Placental growth factor contributes to micro-vascular abnormalization and blood-retinal barrier breakdown in diabetic retinopathy. Kowalczuk L; Touchard E; Omri S; Jonet L; Klein C; Valamanes F; Berdugo M; Bigey P; Massin P; Jeanny JC; Behar-Cohen F PLoS One; 2011 Mar; 6(3):e17462. PubMed ID: 21408222 [TBL] [Abstract][Full Text] [Related]
20. New surgical approach for removing massive foveal hard exudates in diabetic macular edema. Takagi H; Otani A; Kiryu J; Ogura Y Ophthalmology; 1999 Feb; 106(2):249-56; discussion 256-7. PubMed ID: 9951473 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]